Search research articles
Contact Us
Filters
Showing results (681-690 of 756) with videos related to
Page
of 76
Sort By:
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
January 25, 2024
Assessment of the performance of the Ames MPF™ assay: A multicenter collaborative study with six coded chemicals
Dimitrios Spiliotopoulos, Cécile Koelbert, Marc Audebert, et al.
Journal of Crohn'S & Colitis
|
January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study
Antoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2020
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Aurélien Amiot, Jérôme Filippi, Vered Abitbol, et al.
The Lancet. Gastroenterology & Hepatology
|
November 21, 2024
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
Geert D'Haens, Carlos Taxonera, Antonio Lopez-Sanroman, et al.
Alimentary Pharmacology & Therapeutics
|
July 23, 2021
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
Mathurin Fumery, Jérôme Filippi, Vered Abitbol, et al.
The Journal of Biological Chemistry
|
March 15, 2018
Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletions
Olivier Delalande, Anne-Elisabeth Molza, Raphael Dos Santos Morais, et al.
JACC. Cardiooncology
|
February 18, 2026
Systemic Manifestations and Mortality Risk in Transthyretin V142I Variant Carriers: A Million Veteran Program Analysis
Konstantinos Sideris, Tyler J Nelson, Lina Brinker, et al.
Journal of Crohn'S & Colitis
|
February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study
G Pineton de Chambrun, B Pariente, P Seksik, et al.
Digestive Diseases and Sciences
|
March 5, 2022
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study
Lucas Guillo, Aurélien Amiot, Mélanie Serrero, et al.
Journal of Crohn'S & Colitis
|
April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms
Bella Ungar, Karin Malickova, Jurij Hanžel, et al.
Page
of 76
Search research articles
Search
Showing results (681-690 of 756) with videos related to
Sort By:
Page
of 76
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
January 25, 2024
Assessment of the performance of the Ames MPF™ assay: A multicenter collaborative study with six coded chemicals
Dimitrios Spiliotopoulos, Cécile Koelbert, Marc Audebert, et al.
Journal of Crohn'S & Colitis
|
January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort Study
Antoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2020
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Aurélien Amiot, Jérôme Filippi, Vered Abitbol, et al.
The Lancet. Gastroenterology & Hepatology
|
November 21, 2024
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
Geert D'Haens, Carlos Taxonera, Antonio Lopez-Sanroman, et al.
Alimentary Pharmacology & Therapeutics
|
July 23, 2021
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
Mathurin Fumery, Jérôme Filippi, Vered Abitbol, et al.
The Journal of Biological Chemistry
|
March 15, 2018
Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletions
Olivier Delalande, Anne-Elisabeth Molza, Raphael Dos Santos Morais, et al.
JACC. Cardiooncology
|
February 18, 2026
Systemic Manifestations and Mortality Risk in Transthyretin V142I Variant Carriers: A Million Veteran Program Analysis
Konstantinos Sideris, Tyler J Nelson, Lina Brinker, et al.
Journal of Crohn'S & Colitis
|
February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study
G Pineton de Chambrun, B Pariente, P Seksik, et al.
Digestive Diseases and Sciences
|
March 5, 2022
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study
Lucas Guillo, Aurélien Amiot, Mélanie Serrero, et al.
Journal of Crohn'S & Colitis
|
April 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms
Bella Ungar, Karin Malickova, Jurij Hanžel, et al.
Page
of 76